Zydus launches cancer biosimilar nivolumab at steep discount by Live mint | January 22, 2026 8:10 pm | Indian Stocks, Market, News The launch follows a Delhi High Court nod allowing sales of the cancer drug biosimilar ahead of patent expiry in May 2026.
